← Eichor
Study identifier: NCT07114913 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Symptom Distribution and Pain Sensitization in Carpal Tunnel Syndrome

Condition: Carpal Tunnel Syndrome · Central Sensitisation · Pain, Radiating  ·  Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This study aims to compare central sensitization parameters between carpal tunnel syndrome (CTS) patients with extra median symptom distribution and those with typical, median nerve-related symptoms. Extra median sensory spread, observed in some CTS patients beyond the anatomical boundaries of the median nerve, may reflect central sensitization mechanisms. Using the Central Sensitization Inventory and pressure pain threshold measurements, this study will assess whether extra median symptom patterns are associated with increased central sensitization.

This description comes directly from the study's public registry record.

Talk to the study team

Feyza Nur Yücel, Specialist  ·  (0216) 542 20 00  ·  dr.fny28@gamil.com

Emre Ata, Assoc. Prof  ·  (0216) 542 20 00

Always discuss trial participation with your own doctor first.

Locations (1)

Sultan Abdülhamid Han Training and Research HospitalIstanbul, Usküdar, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07114913